Related references
Note: Only part of the references are listed.Targeted a-Emitter Therapy with 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial
Ebrahim S. Delpassand et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Harnessing α-Emitting Radionuclides for Therapy: Radiolabeling Method Review
Hua Yang et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
First In Vivo and Phantom Imaging of Cyclotron-Produced 133La as a Theranostic Radionuclide for 225Ac and 135La
Bryce J. B. Nelson et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target
Bryce Nelson et al.
NUCLEAR MEDICINE AND BIOLOGY (2022)
Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy
Bryce J. B. Nelson et al.
NUCLEAR MEDICINE AND BIOLOGY (2022)
Production of GMP-Compliant Clinical Amounts of Copper-61 Radiopharmaceuticals from Liquid Targets
Alexandra I. Fonseca et al.
PHARMACEUTICALS (2022)
SPECT imaging of 226Ac as a theranostic isotope for 225Ac radiopharmaceutical development
Helena Koniar et al.
PHYSICS IN MEDICINE AND BIOLOGY (2022)
Efficient Production of the PET Radionuclide 133La for Theranostic Purposes in Targeted Alpha Therapy Using the 134Ba(p,2n)133La Reaction
Santiago Andres Bruehlmann et al.
PHARMACEUTICALS (2022)
Developing the 134Ce and 134La pair as companion positron emission tomography diagnostic isotopes for 225Ac and 227Th radiotherapeutics
Tyler A. Bailey et al.
NATURE CHEMISTRY (2021)
Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications
Bryce J. B. Nelson et al.
PHARMACEUTICS (2021)
Cyclotron-Produced 132La as a PET Imaging Surrogate for Therapeutic 225Ac
Eduardo Aluicio-Sarduy et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair
Brooke L. McNeil et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2021)
Preclinical Evaluation of 203/212Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
Sangeeta Ray Banerjee et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
VCAM-1 targeted alpha-particle therapy for early brain metastases
Aurelien Corroyer-Dulmont et al.
NEURO-ONCOLOGY (2020)
Establishing Radiolanthanum Chemistry for Targeted Nuclear Medicine Applications
Eduardo Aluicio-Sarduy et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Pb-212 alpha-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study
Isabelle Quelven et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Taking cyclotron 68Ga production to the next level: Expeditious solid target production of 68Ga for preparation of radiotracers
Bryce J. B. Nelson et al.
NUCLEAR MEDICINE AND BIOLOGY (2020)
203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer
Mengshi Li et al.
CURRENT MEDICINAL CHEMISTRY (2020)
High yield cyclotron production of a novel 133/135La theranostic pair for nuclear medicine
Bryce J. B. Nelson et al.
SCIENTIFIC REPORTS (2020)
Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy
Outi Keinanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Preclinical Investigation of 212Pb-DOTAMTATE for Peptide Receptor Radionuclide Therapy in a Neuroendocrine Tumor Model
Tania A. Rozgaja Stallons et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma Targeting
Jianquan Yang et al.
MOLECULAR PHARMACEUTICS (2019)
Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma
Mengshi Li et al.
MOLECULAR PHARMACEUTICS (2019)
Production and in vivo PET/CT imaging of the theranostic pair 132/135La
Eduardo Aluicio-Sarduy et al.
SCIENTIFIC REPORTS (2019)
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing the lead into PSMA-targeted alpha therapy?
Jose Carlos dos Santos et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
Benjamin B. Kasten et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
Benjamin B. Kasten et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
Iodine Symporter Targeting with 124I/131I Theranostics
James Nagarajah et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models
Benjamin B. Kasten et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
Automated cassette-based production of high specific activity [203/212pb] peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer
Mengshi Li et al.
APPLIED RADIATION AND ISOTOPES (2017)
Dose Escalation and Dosimetry of First-in-Human α Radioimmunotherapy with 212Pb-TCMC-Trastuzumab
Ruby Meredith et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
212Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint
K. J. Yong et al.
BRITISH JOURNAL OF CANCER (2013)
Comparison between Internalizing Anti-HER2 mAbs and Non-Internalizing Anti-CEA mAbs in Alpha-Radioimmunotherapy of Small Volume Peritoneal Carcinomatosis Using 212Pb
Vincent Boudousq et al.
PLOS ONE (2013)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Molecular Imaging and Radiotherapy: Theranostics for Personalized Patient Management
Irina Velikyan
THERANOSTICS (2012)
The use of radiochromic films to measure and analyze the beam profile of charged particle accelerators
M. A. Avila-Rodriguez et al.
APPLIED RADIATION AND ISOTOPES (2009)
Multimodality therapy: Potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease
Diane E. Milenic et al.
CLINICAL CANCER RESEARCH (2008)
203Pb-labeled α-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection
Yubin Miao et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Potentiation of high-LET radiation by gemcitabine: Targeting HER2 with trastuzumab to treat disseminated peritoneal disease
Diane E. Milenic et al.
CLINICAL CANCER RESEARCH (2007)
Melanoma therapy via peptide-targeted α-radiation
YB Miao et al.
CLINICAL CANCER RESEARCH (2005)
Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes Pb-203 and Pb-212
LL Chappell et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Share Paper
